SCHEMBL4026041

SCHEMBL4026041

CN1C(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C(=O)C1(C)C

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 9/20 0.70
LMNA P02545 2/20 0.70
SMN1; SMN2 Q16637 2/20 0.70
PGR P06401 2/20 0.70
MEN1 O00255 1/20 0.70
TP53 P04637 1/20 0.70
CYP1A2 P05177 1/20 0.70
CYP3A4 P08684 1/20 0.70
CYP2D6 P10635 1/20 0.70
CYP2C9 P11712 1/20 0.70
TSHR P16473 1/20 0.70
ALOX12 P18054 1/20 0.70
NFKB1 P19838 1/20 0.70
CYP2C19 P33261 1/20 0.70
RAB9A P51151 1/20 0.70
KMT2A Q03164 1/20 0.70
PDE4D Q08499 1/20 0.70
NPSR1 Q6W5P4 1/20 0.70
SIRT6 Q8N6T7 1/20 0.55
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL633883 0.87 AR (0.64) ARLMNASMN1; SMN2PGRMEN1
SCHEMBL634846 0.87 AR (0.64) ARLMNASMN1; SMN2PGRMEN1
SCHEMBL7779102 0.87 AR (0.66) ARLMNASMN1; SMN2PGRMEN1
SCHEMBL633848 0.86 AR (0.62) ARLMNASMN1; SMN2PGRMEN1
SCHEMBL7779075 0.86 AR (0.62) ARLMNASMN1; SMN2PGRMEN1
SCHEMBL633318 0.86 AR (0.62) ARLMNASMN1; SMN2PGRMEN1
SCHEMBL634148 0.86 AR (0.62) ARLMNASMN1; SMN2PGRMEN1
SCHEMBL4025724 0.86 AR (0.69) ARLMNASMN1; SMN2PGRMEN1
SCHEMBL1387630 0.86 AR (0.61) ARLMNASMN1; SMN2PGRMEN1
SCHEMBL1387624 0.85 AR (0.60) ARLMNASMN1; SMN2PGRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0494819-B1 Phenylimidazolidines, their process for fabrication, their application as medicaments and the pharmaceutical compositions containing them ROUSSEL UCLAF (FR) 1996-07-10 EP claimed
EP-0494819-A1 Phenylimidazolidines, their process for fabrication, their application as medicaments and the pharmaceutical compositions containing them ROUSSEL UCLAF (FR) 1992-07-15 EP claimed
WO-2009097996-A1 USE OF SUBSTITUTED PHENYLIMIDAZOLIDINES FOR PRODUCING MEDICAMENTS FOR TREATING METABOLIC SYNDROME SANOFI-AVENTIS (FR) 2009-08-13 WO disclosed
CN-1149971-C Cosmetic or pharmaceutical compositions consisting of liposomes ³��-�����շ�˾ 2004-05-19 CN disclosed
EP-0671156-B1 Process to prepare cosmetic or pharmaceutical compositions containing liposomes AVENTIS PHARMA SA (FR) 2001-10-24 EP disclosed
US-6162444-A Cosmetic or pharmaceutical compositions HOECHST MARION ROUSSEL (FR) 2000-12-19 US disclosed
US-RE35956-E Phenylimidazolidines having antiandrogenic activity ROUSSEL UCLAF (FR) 1998-11-10 US disclosed
US-5627201-A Phenylimidazolidines having antiandrogenic activity ROUSSEL UCLAF (FR) 1997-05-06 US disclosed
EP-0494819-B1 Phenylimidazolidines, their process for fabrication, their application as medicaments and the pharmaceutical compositions containing them ROUSSEL UCLAF (FR) 1996-07-10 EP disclosed
EP-0671156-A1 Cosmetic or pharmaceutical compositions containing liposomes ROUSSEL UCLAF (FR) 1995-09-13 EP disclosed
US-5411981-A Phenylimidazolidines having antiandrogenic activity ROUSSEL UCLAF (FR) 1995-05-02 US disclosed
EP-0494819-A1 Phenylimidazolidines, their process for fabrication, their application as medicaments and the pharmaceutical compositions containing them ROUSSEL UCLAF (FR) 1992-07-15 EP disclosed